Source: https://patents.google.com/patent/US9925040B2/en
Timestamp: 2019-04-25 00:44:28
Document Index: 681780793

Matched Legal Cases: ['§ 119', 'Application No. 62', '§ 119', 'Application No. 61', '§ 119', 'Application No. 61', '§ 119', 'Application No. 61', 'Application No. 61']

US9925040B2 - Modular intraocular lens designs, tools and methods - Google Patents
US9925040B2
US9925040B2 US15/218,658 US201615218658A US9925040B2 US 9925040 B2 US9925040 B2 US 9925040B2 US 201615218658 A US201615218658 A US 201615218658A US 9925040 B2 US9925040 B2 US 9925040B2
US15/218,658
US20160331519A1 (en
2016-07-25 Application filed by University of Colorado Boulder, CLARVISTA MEDICAL Inc filed Critical University of Colorado Boulder
2016-11-17 Publication of US20160331519A1 publication Critical patent/US20160331519A1/en
2017-04-24 Assigned to THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE reassignment THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAHOOK, MALIK Y.
2017-04-24 Assigned to CLARVISTA MEDICAL, INC. reassignment CLARVISTA MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCLEAN, Paul, Schieber, Andrew, SUSSMAN, GLENN
2018-03-27 Publication of US9925040B2 publication Critical patent/US9925040B2/en
This application is a continuation of U.S. application Ser. No. 15/150,360, filed May 9, 2016, which is a continuation of U.S. application Ser. No. 14/828,083, filed Aug. 17, 2015, entitled “MODULAR INTRAOCULAR LENS DESIGNS, TOOLS AND METHODS,” now U.S. Pat. No. 9,364,316, which claims the benefits under 35 U.S.C. § 119(e) of priority to U.S. Provisional Patent Application No. 62/110,241, filed Jan. 30, 2015, entitled “MODULAR INTRAOCULAR LENS DESIGNS, TOOLS AND METHODS,” each of which is incorporated herein by reference. This application is related to U.S. patent application Ser. No. 15/176,582, filed Jun. 8, 2016, entitled “MODULAR INTRAOCULAR LENS DESIGNS AND METHODS.” This application also is related to U.S. patent application Ser. No. 15/054,915, filed Feb. 26, 2016, entitled “MODULAR INTRAOCULAR LENS DESIGNS AND METHODS.” This application also is related to U.S. patent application Ser. No. 14/808,022, filed Jul. 24, 2015, entitled “MODULAR INTRAOCULAR LENS DESIGNS AND METHODS,” now U.S. Pat. No. 9,387,069, which is incorporated herein by reference. This application also is related to U.S. patent application Ser. No. 14/610,360, filed Jan. 30, 2015, entitled “MODULAR INTRAOCULAR LENS DESIGNS, TOOLS AND METHODS,” which claims the benefits under 35 U.S.C. § 119(e) of priority to U.S. Provisional Patent Application No. 61/941,167, filed Feb. 18, 2014, entitled “MODULAR INTRAOCULAR LENS DESIGNS, TOOLS AND METHODS,” each of which is incorporated herein by reference. This application also is related to U.S. patent application Ser. No. 13/969,115, filed Aug. 16, 2013, entitled “MODULAR INTRAOCULAR LENS DESIGNS & METHODS,” now U.S. Pat. No. 9,289,287, which claims the benefits under 35 U.S.C. § 119(e) of priority to U.S. Provisional Patent Application No. 61/830,491, filed Jun. 3, 2013, entitled “MODULAR INTRAOCULAR LENS DESIGNS AND METHODS,” each of which is incorporated herein by reference. This application also is related to U.S. patent application Ser. No. 13/937,761, filed Jul. 9, 2013, entitled “MODULAR INTRAOCULAR LENS DESIGNS AND METHODS,” now U.S. Pat. No. 9,125,736, which is incorporated herein by reference. This application also is related to U.S. patent application Ser. No. 13/748,207, filed Jan. 23, 2013, entitled “MODULAR INTRAOCULAR LENS DESIGNS & METHODS,” now U.S. Pat. No. 9,095,424, which claims the benefits under 35 U.S.C. § 119(e) of priority of U.S. Provisional Patent Application No. 61/589,981, filed on Jan. 24, 2012, entitled “LASER ETCHING OF IN SITU INTRAOCULAR LENS AND SUCCESSIVE SECONDARY LENS IMPLANTATION,” and of U.S. Provisional Patent Application No. 61/677,213, filed on Jul. 30, 2012, entitled “MODULAR INTRAOCULAR LENS DESIGNS & METHODS,” each of which is incorporated herein by reference.
an optic for providing an optical correction to an eye;
a ring surrounding the optic, the ring including:
a first rim extending around the optic and disposed on a first side of the optic,
a second rim extending around the optic and disposed on a second side of the optic opposite the first side, and
a recess extending from an outer surface of the ring toward an interior of the ring, the recess including:
a closed end opposite the open end, wherein the open end is at the outer surface of the ring and the closed end is in the interior of the ring; and
a therapeutic agent disposed on the ring, the therapeutic agent being contained in a therapeutic agent-eluting material in the recess, for delivery of the therapeutic agent to the eye,
wherein the optic includes:
a first tab, the first tab being fixed and having a first rigidity, and
a second tab, the second tab being actuatable and having a second rigidity, wherein the first rigidity is relatively greater than the second rigidity, and wherein the second tab is actuatable between (i) a radially-compressed position, for allowing at least one of assembly of the optic to the ring and removal of the optic from the ring, and (ii) an uncompressed extended position, for interlocking of the optic and the ring.
2. The IOL of claim 1, wherein the therapeutic agent includes a drug for treating an eye condition.
3. The IOL of claim 1, wherein the ring includes an aperture and an outer periphery, and the recess is positioned radially-outward of the aperture and radially-inward of the outer periphery.
4. The IOL of claim 1, wherein the first rim and the second rim establish an anterior-posterior thickness of the ring that is greater than a central thickness of the optic.
5. The IOL of claim 1, wherein the optic defines a central visual axis, and the first rim and the second rim flare outwardly toward the central visual axis.
6. The IOL of claim 1, wherein an inside diameter of the second rim is less than an inside diameter of the first rim.
7. The IOL of claim 1, wherein the recess is one of a plurality of discrete recesses extending from the outer surface of the ring toward the interior of the ring.
8. The IOL of claim 7, wherein the plurality of discrete recesses extend from only an anterior-facing outer surface of the second rim.
9. The IOL of claim 1, wherein the therapeutic agent-eluting material is configured as a reservoir for storing the therapeutic agent.
10. The IOL of claim 1, wherein the therapeutic agent-eluting material includes an absorbent porous material.
11. The IOL of claim 1, further including an energy-activatable portion that releases the therapeutic agent when exposed to at least one of electromagnetic energy, thermal energy, and magnetic energy.
12. An intra-ocular lens (IOL) comprising:
a first portion extending around the optic and disposed on an anterior side of the optic, and
a second portion extending around the optic and disposed on a posterior side of the optic; and
a drug carrier disposed on the ring, wherein the drug carrier includes:
a recess extending from one of an anterior-facing surface of the first portion and a posterior-facing surface of the second portion, toward an interior of the ring, the recess including:
a closed end opposite the open end, wherein the open end is at the one of the anterior-facing surface of the first portion and the posterior-facing surface of the second portion, and the closed end is in the interior of the ring, and
a drug-eluting material in the recess configured for delivery of a drug to the eye,
a second tab, the second tab being actuatable and having a second rigidity, the first rigidity being relatively greater than the second rigidity, wherein the second tab is actuatable between (i) a radially-compressed position, for allowing at least one of assembly of the optic to the ring and removal of the optic from the ring, and (ii) an uncompressed extended position, for interlocking of the optic and the ring.
13. The IOL of claim 12, wherein the drug carrier is one of a plurality of discrete drug carriers disposed on the anterior-facing surface of the first portion of the ring.
14. The IOL of claim 12, wherein the drug-eluting material includes a porous material that absorbs the drug.
15. The IOL of claim 1, wherein the ring includes a radially-extending cavity having a shape defined by an anterior wall, a posterior wall, and a lateral wall, the anterior wall, posterior wall, and lateral wall inhibiting relative anterior, posterior, and lateral movement between the ring and the optic.
16. The IOL of claim 1, wherein the recess extends from an anterior-facing outer surface of the ring toward the interior of the ring.
17. The IOL of claim 1, wherein the closed end is formed by internal material of the ring.
18. An intra-ocular lens (IOL) comprising:
an optic portion for providing an optical correction to an eye, wherein the optic portion includes:
a second tab, the second tab being actuatable and having a second rigidity, the first rigidity being relatively greater than the second rigidity;
a peripheral portion extending around an entire circumference of the optic portion; and
a drug-eluting material containing a drug, wherein:
the drug-eluting material is embedded within a plurality of recesses disposed in the peripheral portion,
each recess has an open end, and a closed end opposite the open end, and
the open ends of the plurality of recesses are at one of an anterior-facing surface of the peripheral portion and a posterior-facing surface of the peripheral portion,
wherein the second tab is actuatable between (i) a radially-compressed position, for allowing at least one of assembly of the optic portion to the peripheral portion and removal of the optic portion from the peripheral portion, and (ii) an uncompressed extended position, for interlocking of the optic portion and the peripheral portion.
19. The IOL of claim 18, wherein the drug-eluting material includes a porous material that absorbs the drug.
20. The IOL of claim 18, wherein the drug-eluting material in one of the plurality of recesses releases a different drug than the drug-eluting material in another of the plurality of recesses.
US15/218,658 2012-01-24 2016-07-25 Modular intraocular lens designs, tools and methods Active US9925040B2 (en)
US15/150,360 Continuation US9421088B1 (en) 2012-01-24 2016-05-09 Modular intraocular lens designs, tools and methods
US15/890,914 Continuation US20180161153A1 (en) 2012-01-24 2018-02-07 Modular intraocular lens designs, tools and methods
US20160331519A1 US20160331519A1 (en) 2016-11-17
US9925040B2 true US9925040B2 (en) 2018-03-27
International Search Report and Written Opinion from International App. No. PCT/US2016/060350, dated Jan. 27, 2017 (14 pages).
International Search Report and Written Opinion from International Application No. PCT/US2015/067035, dated Apr. 12, 2016 (17 pages).
US9421088B1 (en) 2016-08-23
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KAHOOK, MALIK Y.;REEL/FRAME:042122/0174
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUSSMAN, GLENN;MCLEAN, PAUL;SCHIEBER, ANDREW;SIGNING DATES FROM 20150815 TO 20150821;REEL/FRAME:042122/0176